We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The U.S. Attorney’s Office for the Southern District of New York issued a subpoena to Horizon requesting information related to its patient assistance programs, the drugmaker disclosed in an SEC filing. Read More
The European Medicines Agency has begun a public consultation on revised module V of the good pharmacovigilance practices on risk management systems, which clarifies what risk management plans should focus on over a product’s lifecycle. Read More
Jordanian drugmaker Hikma Pharmaceuticals will sell off two drugs and relinquish marketing rights to a third to avoid tangling with the Federal Trade Commission on its planned purchase of a Boehringer Ingelheim subsidiary. Read More